moomoo ID:NaN
Log Out
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Do not show
Hide blank lines
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
270.49% 18.57B -10.22% 5.01B -51.14% 5.58B 172.39% 11.43B
Other non cash items
22.58% 158.58M 97.75% 129.37M 165.49% 65.42M 170.16% 24.64M
Change In working capital
-229.77% -339.14M 193.78% 261.33M -214.53% -278.65M -43.51% 243.3M
-Change in receivables
-712.56% -1.62B -201.26% -198.79M 145.00% 196.31M -686.48% -436.21M
-Change in inventory
74.05% -57.48M 50.73% -221.45M -339.93% -449.44M -331.31% -102.16M
-Change in prepaid assets
350.96% 409.49M 18.11% -163.17M 57.30% -199.25M -411.76% -466.65M
-Change in other current assets
-48.06% 66.25M 343.93% 127.55M -849.67% -52.29M -113.66% -5.51M
Cash from discontinued investing activities
Operating cash flow
0.77% 5.37B 0.01% 5.33B 4.52% 5.32B 36.49% 5.09B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
-19.56% -1.58B 4.56% -1.32B 9.55% -1.39B -47.32% -1.53B
Net intangibles purchase and sale
58.64% -179.85M -52.86% -434.86M -99.27% -284.48M 64.49% -142.76M
Net business purchase and sale
77.16% -958.7M -1,793.28% -4.2B -118.45% -221.67M 516.63% 1.2B
Net investment purchase and sale
-93.30% -3.94B -3.01% -2.04B -595.07% -1.98B 71.21% -284.94M
Net other investing changes
-- -- -- -- -647.61% -139.46M -575.38% -18.65M
Cash from discontinued investing activities
Investing cash flow
67.93% -2.52B -105.15% -7.85B -520.73% -3.82B 68.87% -616.1M
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt
-126.06% -1.42B 4.85% 5.45B 1,606.45% 5.2B 413.32% 304.67M
Net common stock issuance
-70.41% -332.93M -509.59% -195.37M 94.70% -32.05M -- -604.42M
Cash dividends paid
20.94% -938.49M -44.81% -1.19B -15.40% -819.69M -57.86% -710.33M
Net other financing activities
671.36% 140.16M -35.88% 18.17M 2.82% 28.34M -63.85% 27.56M
Cash from discontinued financing activities
Financing cash flow
-244.42% -3.23B -20.27% 2.23B 228.61% 2.8B -61.77% -2.18B
Net cash flow
Beginning cash position
-0.07% 10.62B 70.51% 10.63B 68.88% 6.24B 5.41% 3.69B
Current changes in cash
-30.63% -374.95M -106.67% -287.03M 86.96% 4.3B 464.67% 2.3B
Effect of exchange rate changes
-332.03% -649.71M 194.59% 280.02M -60.80% 95.05M 211.33% 242.47M
End cash Position
-9.64% 9.6B -0.07% 10.62B 70.51% 10.63B 68.88% 6.24B
Free cash flow
0.18% 3.47B -3.47% 3.47B 5.56% 3.59B 49.70% 3.4B
Currency Unit

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
CEO: Mr. Yi Li
Market: Pink Market
Listing Date: 12/08/2003
Hot List
SymbolLatest price%Chg